Human papillomavirus vaccination induced oral lichen planus
- PMID: 35298066
- DOI: 10.1111/odi.14190
Human papillomavirus vaccination induced oral lichen planus
Keywords: HPV infection; HPV vaccine; lichen planus; oral.
References
REFERENCES
-
- Kato, S., Kawai, R., Torii, R., Yoshida, W., Sugita, Y., Sato, E., Kubo, K., & Maeda, H. (2013). PP105: Prevalence of human papillomavirus infection in oral lichen planus in Japanese patients. Oral Oncology, 49(Suppl 1), S129-S130. https://doi.org/10.1016/j.oraloncology.2013.03.348
-
- Lai, Y. C., & Yew, Y. W. (2017). Lichen planus and lichenoid drug eruption after vaccination. Cutis, 100(6), E6-E20.
-
- Laschinger, M. E., Schleichert, R. A., & Green, B. (2015). Lichenoid drug eruption after human papillomavirus vaccination. Pediatric Dermatology, 32(2), e48-e49. https://doi.org/10.1111/pde.125163
-
- Maldonado, L., Teague, J. E., Morrow, M. P., Jotova, I., Wu, T. C., Wang, C., Desmarais, C., Boyer, J. D., Tycko, B., Robins, H. S., Clark, R. A., & Trimble, C. L. (2014). Intramuscular therapeutic vaccination targeting HPV16 induces T cell responses that localize in mucosal lesions. Science Translational Medicine, 6(221), 221ra13. https://doi.org/10.1126/scitranslmed.3007323
-
- Pizzatti, L., Ferreli, C., Conti, B., Atzori, L., Pinna, G., Pilloni, L., & Rongioletti, F. (2020). Childhood erythrodermic lichen planus pemphigoides after nonavalent human papillomavirus vaccination. JAAD Case Reports, 6(5), 431-433. https://doi.org/10.1016/j.jdcr.2020.03.008
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
